Zika viral polymerase inhibition using anti‐HCV drugs both in market and under clinical trials
Identifieur interne : 001019 ( Main/Exploration ); précédent : 001018; suivant : 001020Zika viral polymerase inhibition using anti‐HCV drugs both in market and under clinical trials
Auteurs : Abdo A. Elfiky [Égypte, Italie]Source :
- Journal of Medical Virology [ 0146-6615 ] ; 2016-12.
Abstract
In the last few months, a new Zika virus (ZIKV) outbreak evolved in America. In accordance, World Health Organization (WHO) in February 2016 declared it as Public Health Emergency of International Concern (PHEIC). ZIKV infection was reported in more than 60 countries and the disease was spreading since 2007 but with little momentum. Many antiviral drugs are available in market or in laboratories under clinical trials, could affect ZIKV infection. In silico docking study were performed on the ZIKV polymerase to test some of Hepatitis C Virus (HCV) drugs (approved and in clinical trials). The results show potency of almost all of the studied compounds on ZIKV polymerase and hence inhibiting the propagation of the disease. In addition, the study suggested two nucleotide inhibitors (IDX‐184 and MK0608) that may be tested as drugs against ZIKV infection. J. Med. Virol. 88:2044–2051, 2016. © 2016 Wiley Periodicals, Inc.
Url:
DOI: 10.1002/jmv.24678
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000496
- to stream Istex, to step Curation: 000463
- to stream Istex, to step Checkpoint: 000000
- to stream Main, to step Merge: 001021
- to stream Main, to step Curation: 001019
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Zika viral polymerase inhibition using anti‐HCV drugs both in market and under clinical trials</title><author><name sortKey="Elfiky, Abdo A" sort="Elfiky, Abdo A" uniqKey="Elfiky A" first="Abdo A." last="Elfiky">Abdo A. Elfiky</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:06A0D25C0F88E1BCE20F5C028E1A1E05D7F5288A</idno><date when="2016" year="2016">2016</date><idno type="doi">10.1002/jmv.24678</idno><idno type="url">https://api.istex.fr/ark:/67375/WNG-0ZW5TQM3-9/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000496</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000496</idno><idno type="wicri:Area/Istex/Curation">000463</idno><idno type="wicri:Area/Istex/Checkpoint">000000</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000000</idno><idno type="wicri:doubleKey">0146-6615:2016:Elfiky A:zika:viral:polymerase</idno><idno type="wicri:Area/Main/Merge">001021</idno><idno type="wicri:Area/Main/Curation">001019</idno><idno type="wicri:Area/Main/Exploration">001019</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main">Zika viral polymerase inhibition using anti‐HCV drugs both in market and under clinical trials</title><author><name sortKey="Elfiky, Abdo A" sort="Elfiky, Abdo A" uniqKey="Elfiky A" first="Abdo A." last="Elfiky">Abdo A. Elfiky</name><affiliation wicri:level="1"><country xml:lang="fr">Égypte</country><wicri:regionArea>Faculty of Science, Biophysics Department, Cairo University, Giza</wicri:regionArea><wicri:noRegion>Giza</wicri:noRegion></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Égypte</country></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Italie</country></affiliation><affiliation></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Italie</country></affiliation></author></analytic><monogr></monogr><series><title level="j" type="main">Journal of Medical Virology</title><title level="j" type="alt">JOURNAL OF MEDICAL VIROLOGY</title><idno type="ISSN">0146-6615</idno><idno type="eISSN">1096-9071</idno><imprint><biblScope unit="vol">88</biblScope><biblScope unit="issue">12</biblScope><biblScope unit="page" from="2044">2044</biblScope><biblScope unit="page" to="2051">2051</biblScope><biblScope unit="page-count">8</biblScope><date type="published" when="2016-12">2016-12</date></imprint><idno type="ISSN">0146-6615</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0146-6615</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In the last few months, a new Zika virus (ZIKV) outbreak evolved in America. In accordance, World Health Organization (WHO) in February 2016 declared it as Public Health Emergency of International Concern (PHEIC). ZIKV infection was reported in more than 60 countries and the disease was spreading since 2007 but with little momentum. Many antiviral drugs are available in market or in laboratories under clinical trials, could affect ZIKV infection. In silico docking study were performed on the ZIKV polymerase to test some of Hepatitis C Virus (HCV) drugs (approved and in clinical trials). The results show potency of almost all of the studied compounds on ZIKV polymerase and hence inhibiting the propagation of the disease. In addition, the study suggested two nucleotide inhibitors (IDX‐184 and MK0608) that may be tested as drugs against ZIKV infection. J. Med. Virol. 88:2044–2051, 2016. © 2016 Wiley Periodicals, Inc.</div></front></TEI><affiliations><list><country><li>Italie</li><li>Égypte</li></country></list><tree><country name="Égypte"><noRegion><name sortKey="Elfiky, Abdo A" sort="Elfiky, Abdo A" uniqKey="Elfiky A" first="Abdo A." last="Elfiky">Abdo A. Elfiky</name></noRegion><name sortKey="Elfiky, Abdo A" sort="Elfiky, Abdo A" uniqKey="Elfiky A" first="Abdo A." last="Elfiky">Abdo A. Elfiky</name></country><country name="Italie"><noRegion><name sortKey="Elfiky, Abdo A" sort="Elfiky, Abdo A" uniqKey="Elfiky A" first="Abdo A." last="Elfiky">Abdo A. Elfiky</name></noRegion><name sortKey="Elfiky, Abdo A" sort="Elfiky, Abdo A" uniqKey="Elfiky A" first="Abdo A." last="Elfiky">Abdo A. Elfiky</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001019 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001019 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= CovidV2
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:06A0D25C0F88E1BCE20F5C028E1A1E05D7F5288A
|texte= Zika viral polymerase inhibition using anti‐HCV drugs both in market and under clinical trials
}}
| This area was generated with Dilib version V0.6.33. |  |